054670.KS · 대한뉴팜

South Korea · RS rating 35 · As of 2026-10-14

Price5,460.00 KRW
1-day change+1.7%
RS rating (overall / 1M / 3M / 12M)35 / 48 / 33 / 42
StageBasing
Composite / Minervini / CANSLIM score27 / 19 / 48
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q+275.2%
Sales growth Q/Q+2.0%
Distance from 52-week high+27.3%
Market cap (USD)$58.4M
Open South Korea in the interactive screener